Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion type Assertion NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_head.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion description "[We further found that miR-26a exerted its antiangiogenesis function, at least in part, by inhibiting HGF-hepatocyte growth factor receptor (cMet) and its downstream signaling pathway, in turn, suppressing VEGFA production in HCC cells and impairing VEGFR2-signaling in endothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_provenance.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion evidence source_evidence_literature NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_provenance.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion SIO_000772 24259426 NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_provenance.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion wasDerivedFrom befree-2016 NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_provenance.
- NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_assertion wasGeneratedBy ECO_0000203 NP1130078.RAeBvn5NhW3-0GHlRa0GrvqqU4is341sTN2wlci19h2ng130_provenance.